Cognitive-behavioral treatment with behavioral activation for smokers with depressive symptomatology: Study protocol of a randomized controlled trial

Becoña, E. ; Martínez-Vispo, C. ; Senra, C. ; López-Durán, A. ; Rodríguez-Cano, R. ; Fernández Del Río, E. (Universidad de Zaragoza)

Resumen: Background: Smoking is an important risk factor for mental health-related problems. Numerous studies have supported a bi-directional association between cigarette smoking and depression. Despite the advances in understanding the comorbidity between both problems, the most effective psychological treatment that simultaneously targets smoking and depressive symptomatology remains unclear. The objective of this study is to assess the effectiveness of a cognitive-behavioral intervention for smoking cessation with components of behavioral activation for managing depressed mood. Method: A single blind, three-arm, superiority randomized controlled trial is proposed. Participants will be smokers over 18years old, who smoke at least 8 cigarettes per day. Participants will be randomized to one of three conditions, using a 2:2:1 allocation ratio: 1) standard cognitive-behavioral smoking cessation treatment; 2) standard cognitive-behavioral smoking cessation treatment plus behavioral activation; or 3) a three-month delayed treatment control group. The primary outcome measures will be biochemically verified point-prevalence abstinence (carbon monoxide in expired air) and significant change from baseline in depressive symptoms to the end of treatment, and at the 3-, 6-, and 12-month follow-up. Discussion: This study aims to assess the efficacy of a cognitive-behavioral intervention with behavioral activation components for smoking cessation and depressive symptoms, compared to a standard cognitive-behavioral intervention to quit smoking. As the relation between depressive symptoms, even at subclinical levels, and quitting smoking difficulties is well known, we expect that such intervention will allow obtaining higher abstinence rates, lower relapse rates, and mood improvement. Trial registration:ClinicalTrials.gov: NCT02844595. Retrospectively registered 19th July, 2016. The study started in January 2016, and the recruitment is ongoing.

Idioma: Inglés

DOI: 10.1186/s12888-017-1301-7

Año: 2017

Publicado en: BMC Psychiatry 17, 1 (2017), 134 [10pp]
ISSN: 1471-244X

Factor impacto JCR: 2.419 (2017)

Categ. JCR: PSYCHIATRY rank: 71 / 142 = 0.5 (2017) - Q2 - T2

Factor impacto SCIMAGO: 1.346 - Psychiatry and Mental Health (Q1)

Financiación: info:eu-repo/grantAgreement/ES/MINECO/PSI2015-66755-R

Tipo y forma: Article (Published version)

Área (Departamento): Área Psicología Social (Dpto. Psicología y Sociología)